[1]. Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.
Anticancer research [巻]44 [号]2 [頁]781 -786 （2024年） [査読] 有
[DOI] [2]. Robot-assisted radical nephroureterectomy for upper urinary tract tumor: initial experience with the use of novel surgical robot system, hinotori
TRANSLATIONAL CANCER RESEARCH [巻]12 [号]12 [頁]3522 -3529 （2023年） [査読] 有
[DOI] [3]. Robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using the novel surgical robot platform, hinotori: Initial experience with two cases.
IJU case reports [巻]7 [号]2 [頁]96 -99 （2023年） [査読] 有
[DOI] [4]. Perioperative outcomes of robot-assisted partial nephrectomy using hinotori versus da Vinci surgical robot system: a propensity score-matched analysis
JOURNAL OF ROBOTIC SURGERY [巻]17 [号]5 [頁]2435 -2440 （2023年） [査読] 有
[DOI] [5]. Robot-assisted radical nephrectomy using novel surgical robot platform, hinotori: Report of initial series of 13 cases
INTERNATIONAL JOURNAL OF UROLOGY [巻]30 [号]12 [頁]1175 -1179 （2023年） [査読] 有
[DOI]